1_MC1 ._. Introduction_NN1 
Female_JJ anautogenous_JJ mosquitoes_NN2 need_VV0 a_AT1 blood_NN1 meal_NN1 from_II a_AT1 vertebrate_JJ host_NN1 to_TO reproduce_VVI ._. Therefore_RR ,_, they_PPHS2 can_VM act_VVI as_II vectors_NN2 for_IF numerous_JJ pathogens_NN2 ,_, e.g._REX ,_, arthropod-borne_JJ viruses_NN2 (_( arboviruses_NN2 )_) or_CC parasites_NN2 ,_, responsible_JJ for_IF both_RR human_JJ and_CC animal_NN1 diseases_NN2 ._. The_AT most_RGT important_JJ mosquito-borne_JJ viruses_NN2 include_VV0 flaviviruses_NN2 (_( Flaviviridae_NP2 )_) such_II21 as_II22 dengue_NN1 virus_NN1 (_( DENV_NP1 )_) ,_, yellow_JJ fever_NN1 virus_NN1 (_( YFV_NP1 )_) ,_, West_ND1 Nile_NP1 virus_NN1 (_( WNV_NP1 )_) ;_; alphaviruses_NN2 (_( Togaviridae_NP2 )_) such_II21 as_II22 chikungunya_NN1 virus_NN1 (_( CHIKV_NP1 )_) ,_, o'nyong-nyong_NN1 virus_NN1 (_( ONNV_NP1 )_) ,_, Semliki_NP1 Forest_NP1 virus_NN1 (_( SFV_NP1 )_) ,_, Sindbis_NP1 virus_NN1 (_( SINV_NP1 )_) ;_; and_CC bunyaviruses_NN2 (_( Bunyaviridae_NP2 )_) such_II21 as_II22 Rift_NP1 Valley_NP1 fever_NN1 virus_NN1 (_( RVFV_NP1 )_) ._. All_DB of_IO these_DD2 arboviruses_NN2 are_VBR mainly_RR transmitted_VVN by_II aedine_JJ species_NN including_II Aedes_NP121 aegypti_NP122 and_CC Ae._NP121 albopictus_NP122 as_II31 well_II32 as_II33 Culex_NP1 species_NN ,_, with_IW the_AT exception_NN1 of_IO ONNV_NP1 which_DDQ is_VBZ the_AT only_JJ known_JJ arbovirus_NN1 to_TO be_VBI transmitted_VVN by_II Anopheles_NP2 ,_, and_CC more_RGR specifically_RR the_AT African_JJ malaria_NN1 vector_NN1 An._NP121 gambiae_NP122 ._. In_II recent_JJ decades_NNT2 ,_, the_AT incidence_NN1 of_IO mosquito-borne_JJ viral_JJ infections_NN2 has_VHZ grown_VVN dramatically_RR ._. For_REX21 example_REX22 ,_, according_II21 to_II22 the_AT World_NP1 Health_NP1 Organization_NP1 (_( WHO_NP1 )_) ,_, more_DAR than_CSN 2.5_MC billion_NNO people_NN –_– over_RG 40_MC %_NNU of_IO the_AT world_NN1 's_GE population_NN1 –_– are_VBR estimated_VVN to_TO be_VBI at_II risk_NN1 from_II DENV_NP1 alone_RR ._. A_AT1 recent_JJ study_NN1 has_VHZ evaluated_VVN the_AT incidence_NN1 of_IO dengue_NN1 infections_NN2 to_TO be_VBI around_RG 390_MC million_NNO worldwide_RL every_AT1 year_NNT1 ,_, of_IO which_DDQ 96_MC million_NNO manifest_JJ [_[ 1_MC1 ]_] ._. Moreover_RR ,_, mosquito-borne_JJ virus_NN1 infections_NN2 are_VBR continuously_RR expanding_VVG their_APPGE geographical_JJ range_NN1 into_II new_JJ areas_NN2 ._. The_AT spread_NN1 of_IO infections_NN2 from_II Africa_NP1 and_CC Asia_NP1 to_II other_JJ continents_NN2 is_VBZ thought_VVN to_TO be_VBI due_II21 to_II22 extensive_JJ travelling_NN1 ,_, trade_NN1 ,_, population_NN1 growth_NN1 in_II high-risk_JJ areas_NN2 ,_, globalization_NN1 of_IO vectors_NN2 ,_, urbanization_NN1 ,_, climatic_JJ change_NN1 ,_, as_II31 well_II32 as_II33 virus_NN1 genome_NN1 evolution_NN1 [_[ 2–4_MCMC ]_] ._. The_AT threat_NN1 of_IO a_AT1 possible_JJ outbreak_NN1 of_IO dengue_NN1 fever_NN1 now_RT exists_VVZ in_II Europe_NP1 ._. Local_JJ transmission_NN1 of_IO DENV_NP1 by_II Ae._NP121 albopictus_NP122 was_VBDZ reported_VVN for_IF the_AT first_MD time_NNT1 in_II France_NP1 and_CC Croatia_NP1 in_II 2010_MC ,_, and_CC imported_JJ cases_NN2 were_VBDR detected_VVN in_II three_MC other_JJ European_JJ countries_NN2 ._. Moreover_RR ,_, an_AT1 epidemic_NN1 was_VBDZ reported_VVN in_II Madeira_NP1 (_( Portugal_NP1 )_) in_II 2012–2013_MCMC in_II which_DDQ 2200_MC patients_NN2 tested_VVD positive_JJ for_IF DENV_NP1 ,_, 78_MC of_IO whom_PNQO were_VBDR known_VVN to_TO have_VHI travelled_VVN away_II21 from_II22 the_AT island_NN1 ._. This_DD1 spread_NN1 of_IO DENV_NP1 was_VBDZ aided_VVN by_II the_AT establishment_NN1 of_IO Ae._NP121 aegypti_NP122 in_II the_AT region_NN1 ._. Moreover_RR ,_, imported_JJ cases_NN2 have_VH0 been_VBN detected_VVN in_II a_AT1 further_JJR 10_MC European_JJ countries_NN2 in_II31 addition_II32 to_II33 mainland_NN1 Portugal_NP1 [_[ 5–8_MCMC ]_] ._. In_II 2005–2006_MCMC ,_, an_AT1 outbreak_NN1 of_IO CHIKV_NP1 ,_, normally_RR transmitted_VVN by_II Ae._NP121 aegypti_NP122 ,_, occurred_VVD in_II the_AT Indian_NP1 Ocean_NNL1 ._. This_DD1 epidemic_NN1 has_VHZ been_VBN associated_VVN with_IW a_AT1 single_JJ nucleotide_NN1 mutation_NN1 in_II the_AT viral_JJ E1_NP1 glycoprotein_NN1 conferring_VVG more_RGR efficient_JJ dissemination_NN1 and_CC transmission_NN1 by_II the_AT secondary_JJ vector_NN1 ,_, Ae._NP121 albopictus_NP122 ,_, which_DDQ is_VBZ more_RGR prevalent_JJ in_II this_DD1 region_NN1 [_[ 9–11_MCMC ]_] ._. Given_VVN the_AT worldwide_JJ distribution_NN1 of_IO Ae._NP1 albopictus_NP122 ,_, this_DD1 CHIKV_NP1 variant_NN1 has_VHZ spread_VVN into_II many_DA2 countries_NN2 [_[ 12_MC ]_] ._. Currently_RR ,_, there_EX is_VBZ a_AT1 large_JJ CHIKV_NP1 outbreak_NN1 occurring_VVG in_II the_AT Americas_NP2 ,_, which_DDQ started_VVD in_II 2013_MC with_IW the_AT first_MD reported_JJ cases_NN2 of_IO autochthonous_JJ transmission_NN1 on_II this_DD1 continent_NN1 ._. According_II21 to_II22 the_AT Pan_NP1 America_NP1 Health_NP1 Organization_NP1 (_( PAHO_NP1 )_) /_/ WHO_NP1 ,_, as_II21 of_II22 February_NPM1 2015_MC ,_, local_JJ transmission_NN1 has_VHZ been_VBN identified_VVN in_II 50_MC countries_NN2 or_CC territories_NN2 in_II the_AT Caribbean_NP1 ,_, Central_JJ America_NP1 ,_, South_ND1 America_NP1 ,_, and_CC North_ND1 America_NP1 ._. From_II the_AT beginning_NN1 of_IO the_AT epidemic_NN1 in_II 2013_MC up_II21 to_II22 February_NPM1 2015_MC ,_, a_AT1 total_NN1 of_IO 1,176,216_MC suspected_JJ and_CC 27,136_MC laboratory-confirmed_JJ chikungunya_NN1 cases_NN2 have_VH0 been_VBN reported_VVN from_II these_DD2 areas_NN2 ._. CHIKV_NP1 will_VM likely_RR continue_VVI to_TO spread_VVI to_II new_JJ areas_NN2 in_II the_AT Americas_NP2 through_II the_AT movement_NN1 of_IO infected_JJ people_NN and_CC mosquitoes_NN2 to_II naïve_JJ regions_NN2 [_[ 4,12,13_MC ]_] ._. 
There_EX are_VBR currently_RR no_AT vaccines_NN2 for_IF a_AT1 number_NN1 of_IO important_JJ human-infecting_JJ arboviruses_NN2 including_II DENV_NP1 and_CC CHIKV_NP1 ._. Therefore_RR ,_, the_AT control_NN1 of_IO mosquito_NN1 vectors_NN2 is_VBZ still_RR the_AT main_JJ tool_NN1 to_TO eradicate_VVI ,_, or_CC at_RR21 least_RR22 reduce_VVI ,_, the_AT incidence_NN1 of_IO arboviral_JJ diseases_NN2 [_[ 14_MC ]_] ._. Insecticides_NN2 ,_, nets_NN2 and_CC the_AT reduction_NN1 of_IO breeding_NN1 sites_NN2 are_VBR currently_RR the_AT main_JJ tools_NN2 for_IF mosquito_NN1 vector_NN1 control_NN1 ._. However_RR ,_, growing_JJ insecticide_NN1 resistance_NN1 in_II mosquito_NN1 vectors_NN2 has_VHZ increasingly_RR limited_VVN the_AT utility_NN1 of_IO chemical_JJ insecticides_NN2 [_[ 15–18_MCMC ]_] ._. Moreover_RR ,_, biting_NN1 patterns_NN2 of_IO Ae._NP121 aegypti_NP122 and_CC Ae._NP121 albopictus_NP122 ,_, mainly_RR during_II the_AT day_NNT1 ,_, makes_VVZ the_AT use_NN1 of_IO bed_NN1 nets_NN2 rather_RG ineffective_JJ ._. On_II the_AT other_JJ hand_NN1 ,_, larval_JJ habitats_NN2 may_VM be_VBI small_JJ ,_, widely_RR dispersed_JJ ,_, and_CC transient_JJ and_CC it_PPH1 is_VBZ difficult_JJ ,_, if_CS not_XX impossible_JJ ,_, to_TO predict_VVI when_RRQ and_CC where_RRQ the_AT breeding_NN1 sites_NN2 will_VM form_VVI ,_, to_TO find_VVI and_CC treat_VVI them_PPHO2 before_II the_AT adults_NN2 emerge_VV0 ._. Thus_RR ,_, alternative_JJ methods_NN2 of_IO mosquito_NN1 control_NN1 are_VBR urgently_RR needed_VVN ._. 
The_AT efficiency_NN1 of_IO mosquito-borne_JJ disease_NN1 transmission_NN1 under_II natural_JJ conditions_NN2 is_VBZ referred_VVN to_II as_II the_AT vectorial_JJ capacity_NN1 ,_, which_DDQ is_VBZ modelled_VVN by_II the_AT following_JJ equation_NN1 ,_, first_MD developed_VVN for_IF modeling_VVG malaria_NN1 transmission_NN1 by_II Ross_NP1 in_II 1910_MC and_CC later_RRR refined_VVN by_II others_NN2 [_[ 19_MC ]_] :_: 

This_DD1 mathematical_JJ model_NN1 ,_, which_DDQ can_VM be_VBI applied_VVN to_II arbovirus_NN1 transmission_NN1 ,_, shows_VVZ that_CST vectorial_JJ capacity_NN1 (_( C_FO )_) depends_VVZ on_II many_DA2 factors_NN2 including_II :_: the_AT abundance_NN1 of_IO vector_NN1 mosquitoes_NN2 per_II vertebrate_JJ host_NN1 (_( m_FO )_) ;_; the_AT probability_NN1 of_IO a_AT1 bite_NN1 occurring_VVG (_( a_FO )_) ;_; the_AT probability_NN1 of_IO vector_NN1 survival_NN1 (_( p_FO )_) ;_; the_AT duration_NN1 of_IO the_AT incubation_NN1 period_NN1 after_II which_DDQ the_AT vector_NN1 can_VM transmit_VVI the_AT virus_NN1 (_( n_FO )_) ;_; the_AT probability_NN1 of_IO vector_NN1 survival_NN1 after_II the_AT incubation_NN1 period_NN1 is_VBZ completed_VVN (_( 1/-ln(p)_FO )_) ;_; and_CC the_AT vector_NN1 competence_NN1 (_( b_FO )_) ._. Mosquito_NN1 vector_NN1 competence_NN1 for_IF arboviruses_NN2 is_VBZ an_AT1 evaluation_NN1 of_IO the_AT mosquito_NN1 's_GE ability_NN1 to_TO become_VVI infected_JJ following_II an_AT1 infectious_JJ blood_NN1 meal_NN1 and_CC to_TO subsequently_RR transmit_VVI the_AT virus_NN1 ._. After_CS the_AT ingestion_NN1 of_IO an_AT1 arbovirus_NN1 by_II the_AT female_JJ mosquito_NN1 ,_, it_PPH1 must_VM overcome_VVI different_JJ barriers_NN2 in_BCL21 order_BCL22 to_TO be_VBI transmitted_VVN ._. The_AT first_MD is_VBZ the_AT midgut_NN1 infection_NN1 barrier_NN1 (_( MIB_NP1 )_) before_II the_AT virus_NN1 can_VM invade_VVI the_AT midgut_NN1 epithelium_NN1 where_CS it_PPH1 undergoes_VVZ replication_NN1 in_BCL21 order_BCL22 to_TO pass_VVI through_II the_AT midgut_NN1 escape_NN1 barrier_NN1 (_( MEB_NP1 )_) and_CC then_RT disseminate_VVI to_II other_JJ tissues_NN2 ,_, finally_RR reaching_VVG and_CC infecting_VVG the_AT salivary_JJ glands_NN2 ._. The_AT salivary_JJ gland_NN1 infection_NN1 barrier_NN1 (_( SIB_NP1 )_) and_CC salivary_JJ gland_NN1 escape_NN1 barrier_NN1 (_( SEB_NP1 )_) are_VBR the_AT final_JJ hurdles_NN2 for_IF arboviruses_NN2 to_TO overcome_VVI before_CS they_PPHS2 can_VM be_VBI transmitted_VVN during_II a_AT1 subsequent_JJ mosquito_NN1 blood_NN1 meal_NN1 [_[ 20–22_MCMC ]_] ._. Mosquito_NN1 vector_NN1 competence_NN1 for_IF arboviruses_NN2 has_VHZ been_VBN shown_VVN to_TO be_VBI determined_VVN by_II the_AT genetic_JJ components_NN2 of_IO both_DB2 the_AT mosquito_NN1 and_CC arbovirus_NN1 and_CC their_APPGE interactions_NN2 ,_, a_AT1 phenomenon_NN1 called_VVN genotype-genotype_NN1 (_( GXG_NP1 )_) interactions_NN2 ._. Therefore_RR ,_, mosquito_NN1 vector_NN1 competence_NN1 can_VM vary_VVI among_II mosquito_NN1 vector_NN1 /_/ arbovirus_NN1 species_NN and_CC strains_NN2 as_II31 well_II32 as_II33 between_II individual_JJ mosquitoes_NN2 within_II one_MC1 strain_NN1 [_[ 20_MC ,_, 23_MC ,_, 24_MC ]_] ._. As_CSA arboviruses_NN2 often_RR exist_VV0 as_II a_AT1 collection_NN1 of_IO variable_JJ genomes_NN2 within_II and_CC among_II hosts_NN2 ,_, referred_VVN to_II as_II a_AT1 mutant_NN1 swarm_NN1 [_[ 25_MC ]_] ,_, vector_NN1 competence_NN1 can_VM also_RR vary_VVI depending_II21 on_II22 the_AT genome_NN1 population_NN1 of_IO an_AT1 arbovirus_NN1 strain_NN1 ._. Moreover_RR ,_, mosquito_NN1 vector_NN1 competence_NN1 is_VBZ dependent_JJ on_II environmental_JJ parameters_NN2 such_II21 as_II22 temperature_NN1 or_CC symbiotic_JJ microbiota_NN2 ,_, as_CSA previously_RR reviewed_VVN [_[ 24_MC ,_, 26_MC ]_] ._. Thus_RR ,_, a_AT1 considerable_JJ number_NN1 of_IO factors_NN2 can_VM influence_VVI competence_NN1 ,_, even_RR in_II a_AT1 same_DA mosquito_NN1 /_/ arbovirus_NN1 spp._NN2 combination_NN1 ._. 
A_AT1 change_NN1 in_II any_DD of_IO the_AT parameters_NN2 of_IO vectorial_JJ capacity_NN1 for_IF a_AT1 specific_JJ pathogen_NN1 can_VM affect_VVI the_AT spread_NN1 of_IO a_AT1 disease_NN1 ._. Therefore_RR ,_, control_NN1 of_IO Aedes_NP1 mosquito_NN1 vectors_NN2 either_RR by_II mosquito_NN1 population_NN1 reduction_NN1 or_CC replacement_NN1 with_IW refractory_JJ mosquitoes_NN2 can_VM play_VVI an_AT1 important_JJ role_NN1 in_II the_AT fight_NN1 against_II arboviral_JJ infectious_JJ diseases_NN2 ._. The_AT reduction_NN1 of_IO populations_NN2 is_VBZ aimed_VVN at_II decreasing_VVG the_AT probability_NN1 of_IO vector_NN1 survival_NN1 (_( p_FO )_) and_CC the_AT abundance_NN1 of_IO vector_NN1 mosquitoes_NN2 per_II vertebrate_JJ host_NN1 (_( m_FO )_) leading_VVG to_II a_AT1 decrease_NN1 in_II disease_NN1 transmission_NN1 ._. Proof-of-principle_NN1 experiments_NN2 and_CC field_NN1 trials_NN2 of_IO such_DA strategies_NN2 in_II Ae._NP121 aegypti_NP122 have_VH0 already_RR been_VBN carried_VVN out_RP using_VVG endosymbiotic_JJ Wolbachia_NP1 bacteria_NN2 [_[ 27_MC ,_, 28_MC ]_] or_CC genetically_RR modified_JJ (_( GM_NP1 )_) mosquitoes_NN2 with_IW the_AT RIDL_NP1 (_( "_" Release_NP1 of_IO Insects_NP2 carrying_VVG a_AT1 Dominant_JJ Lethal_NN1 "_" )_) genetic_JJ system_NN1 [_[ 29_MC ]_] ._. Replacing_VVG competent_JJ mosquito_NN1 populations_NN2 with_IW refractory_JJ mosquitoes_NN2 aims_VVZ to_TO reduce_VVI vector_NN1 competence_NN1 (_( b_FO )_) ._. Although_CS vector_NN1 competence_NN1 is_VBZ not_XX the_AT most_RGT important_JJ determinant_NN1 of_IO vectorial_JJ capacity_NN1 ,_, vectorial_JJ capacity_NN1 fluctuates_VVZ directly_RR with_IW it_PPH1 as_CSA competence_NN1 is_VBZ a_AT1 linear_JJ term_NN1 in_II expressions_NN2 of_IO vectorial_JJ capacity_NN1 ._. Therefore_RR ,_, reducing_VVG vector_NN1 competence_NN1 should_VM lead_VVI to_II a_AT1 decrease_NN1 in_II the_AT spread_NN1 of_IO a_AT1 disease_NN1 ._. Recently_RR ,_, significant_JJ advances_NN2 in_II knowledge_NN1 about_II the_AT mechanisms_NN2 of_IO interactions_NN2 between_II mosquitoes_NN2 and_CC arboviruses_NN2 have_VH0 been_VBN made_VVN ,_, especially_RR regarding_II the_AT influence_NN1 of_IO mosquito_NN1 antiviral_JJ responses_NN2 on_II arbovirus_NN1 propagation_NN1 ,_, genetic_JJ and_CC phenotypic_JJ variation_NN1 affecting_VVG these_DD2 interactions_NN2 ,_, the_AT impact_NN1 of_IO these_DD2 interactions_NN2 on_II mosquito_NN1 fitness_NN1 ,_, and_CC how_RRQ environmental_JJ factors_NN2 affect_VV0 arbovirus_NN1 transmission_NN1 [_[ 23_MC ,_, 26_MC ,_, 30_MC ,_, 31_MC ]_] ._. This_DD1 opens_VVZ the_AT way_NN1 for_IF the_AT development_NN1 of_IO novel_JJ disease_NN1 control_NN1 strategies_NN2 by_II altering_VVG mosquito_NN1 vector_NN1 competence_NN1 ._. 
In_II this_DD1 review_NN1 ,_, we_PPIS2 will_VM focus_VVI on_II the_AT development_NN1 and_CC application_NN1 of_IO biological_JJ approaches_NN2 ,_, either_RR natural_JJ or_CC engineered_JJ ,_, to_TO limit_VVI mosquito_NN1 vector_NN1 competence_NN1 for_IF arboviruses_NN2 in_II Aedes_NP1 spp._NN2 vectors_NN2 ._. For_IF overall_JJ relevance_NN1 ,_, some_DD results_NN2 obtained_VVN with_IW other_JJ mosquito_NN1 species_NN ,_, such_II21 as_II22 Culex_NP1 or_CC Anopheles_NP1 ,_, will_VM also_RR be_VBI reviewed_VVN ._. We_PPIS2 discuss_VV0 key_JJ aspects_NN2 of_IO mosquito_NN1 antiviral_JJ pathways_NN2 as_II targets_NN2 ,_, either_RR for_IF the_AT selection_NN1 of_IO naturally_RR resistant_JJ mosquito_NN1 populations_NN2 or_CC for_IF engineering_JJ transgenic_JJ mosquitoes_NN2 resistant_JJ to_II viral_JJ infections_NN2 ._. We_PPIS2 will_VM also_RR consider_VVI the_AT use_NN1 of_IO endosymbiotic_JJ bacteria_NN2 such_II21 as_II22 Wolbachia_NP1 ,_, which_DDQ in_II some_DD cases_NN2 have_VH0 proven_VVN to_TO be_VBI remarkably_RR efficient_JJ in_II disrupting_VVG arbovirus_NN1 transmission_NN1 by_II mosquitoes_NN2 ._. Further_RRR to_II this_DD1 ,_, we_PPIS2 will_VM discuss_VVI the_AT use_NN1 of_IO naturally_RR occurring_JJ insect-specific_JJ viruses_NN2 that_DD1 may_VM interfere_VVI with_IW arboviruses_NN2 in_II mosquito_NN1 vectors_NN2 as_II31 well_II32 as_II33 paratransgenesis_NN1 of_IO endosymbionts_NN2 to_TO control_VVI mosquito_NN1 vector_NN1 competence_NN1 ._. 
2_MC ._. Natural_JJ Control_NN1 of_IO Arbovirus_NN1 Transmission_NN1 
2.1_MC ._. Mosquitoes_NN2 Naturally_RR Resistant_JJ to_II Arbovirus_NN1 Transmission_NN1 
Although_CS genetic_JJ engineering_NN1 strategies_NN2 to_TO reduce_VVI Aedes_NP1 mosquito_NN1 populations_NN2 [_[ 29_MC ]_] and_CC the_AT use_NN1 of_IO Wolbachia_NP1 bacteria_NN2 [_[ 32_MC ]_] have_VH0 generated_VVN new_JJ opportunities_NN2 in_II vector_NN1 control_NN1 ,_, investigations_NN2 into_II natural_JJ mosquito_NN1 competence_NN1 can_VM serve_VVI to_TO identify_VVI new_JJ targets_NN2 for_IF mosquito_NN1 transgenic_JJ engineering_NN1 or_CC select_VVI resistant_JJ mosquitoes_NN2 by_II breeding_NN1 for_IF population_NN1 replacement_NN1 strategies_NN2 ._. As_CSA defined_VVN in_II the_AT introduction_NN1 ,_, natural_JJ competence_NN1 for_IF pathogens_NN2 can_VM be_VBI due_II21 to_II22 a_AT1 number_NN1 of_IO factors_NN2 [_[ 24_MC ,_, 26_MC ,_, 30_MC ]_] ._. If_CS environmental_JJ factors_NN2 and_CC viral_JJ properties_NN2 are_VBR excluded_VVN ,_, mosquito_NN1 cellular_JJ factors_NN2 such_II21 as_II22 receptors_NN2 or_CC proteins_NN2 ,_, extracellular_JJ factors_NN2 and_CC tissue-related_JJ properties_NN2 (_( accessibility_NN1 ,_, cell_NN1 types_NN2 )_) can_VM all_DB potentially_RR influence_VVI arbovirus_NN1 midgut_NN1 infection_NN1 ,_, replication_NN1 and_CC dissemination_NN1 to_II the_AT saliva_NN1 ._. Many_DA2 experimental_JJ studies_NN2 have_VH0 compared_VVN competence_NN1 for_IF arboviruses_NN2 between_II regional_JJ strains_NN2 of_IO mosquito_NN1 species_NN or_CC between_II species_NN of_IO mosquitoes_NN2 and_CC this_DD1 section_NN1 shall_VM only_RR address_VVI work_NN1 where_CS differences_NN2 at_II genetic_JJ /_/ molecular_JJ /_/ physiological_JJ levels_NN2 were_VBDR observed_VVN that_DD1 may_VM inform_VVI vector_NN1 control_NN1 strategies_NN2 ._. 
One_MC1 of_IO the_AT first_MD observations_NN2 made_VVN was_VBDZ that_CST a_AT1 laboratory_NN1 strain_NN1 of_IO Culex_NP131 pipiens_NP132 pipiens_NP133 (_( Cx._NP131 pipiens_NP132 pipiens_NP133 )_) ,_, a_AT1 natural_JJ vector_NN1 of_IO WNV_NP1 ,_, was_VBDZ refractory_JJ to_II this_DD1 virus_NN1 ._. Studies_NN2 on_II the_AT midgut_NN1 of_IO these_DD2 mosquitoes_NN2 revealed_VVD an_AT1 induction_NN1 of_IO apoptosis_NN1 in_II this_DD1 tissue_NN1 ,_, which_DDQ the_AT authors_NN2 linked_VVD to_II a_AT1 failure_NN1 to_TO disseminate_VVI virus_NN1 from_II the_AT midgut_NN1 [_[ 33_MC ]_] ._. 
Analysis_NN1 of_IO quantitative_JJ trait_NN1 loci_NN2 in_II Ae._NP121 aegypti_NP122 has_VHZ identified_VVN targets_NN2 and_CC given_VVN further_RRR insights_NN2 into_II the_AT genetics_NN1 of_IO DENV_NP1 competence_NN1 related_JJ to_TO midgut_VVI infection_NN1 and_CC escape_NN1 barriers_NN2 [_[ 34–37_MCMC ]_] ._. However_RR ,_, while_CS these_DD2 loci_NN2 can_VM be_VBI pinpointed_VVN to_II individual_JJ chromosomes_NN2 ,_, the_AT host_NN1 genes_NN2 remain_VV0 to_TO be_VBI identified_VVN ._. Advances_NN2 in_II sequencing_NN1 technologies_NN2 over_II the_AT last_MD three_MC to_II five_MC years_NNT2 may_VM now_RT allow_VVI these_DD2 data_NN and_CC mosquito_NN1 strains_NN2 to_TO be_VBI analyzed_VVN further_RRR and_CC candidate_NN1 regions_NN2 to_TO be_VBI assessed_VVN in_RR21 vivo_RR22 ._. Nonetheless_RR ,_, some_DD progress_NN1 on_II identifying_VVG the_AT role_NN1 of_IO individual_JJ host_NN1 molecules_NN2 and_CC their_APPGE role_NN1 in_II competence_NN1 has_VHZ been_VBN made_VVN ._. 
A_AT1 putative_JJ DENV_NP1 receptor_NN1 present_JJ in_II mosquitoes_NN2 that_DD1 can_VM be_VBI infected_VVN with_IW dengue_NN1 was_VBDZ identified_VVN [_[ 38_MC ]_] ,_, though_CS more_RGR detailed_JJ descriptions_NN2 and_CC assays_NN2 such_II21 as_II22 knock_NN1 down_RP studies_NN2 are_VBR required_VVN to_TO confirm_VVI this_DD1 finding_NN1 ._. More_RGR recently_RR ,_, Lambrechts_NP1 and_CC colleagues_NN2 [_[ 39_MC ]_] suggested_VVD that_CST polymorphisms_NN2 in_II the_AT Ae._NP121 aegypti_NP122 Dicer2_NP1 (_( Dcr2_NP1 ,_, a_AT1 key_JJ exogenous_JJ siRNAi_NP1 pathway_NN1 protein_NN1 )_) are_VBR associated_VVN with_IW resistance_NN1 to_II DENV_NP1 ._. While_CS the_AT exact_JJ mechanism_NN1 of_IO virus_NN1 resistance_NN1 due_II21 to_II22 Dcr2_NP1 polymorphisms_NN2 is_VBZ not_XX known_VVN ,_, these_DD2 findings_NN2 directly_RR link_VV0 mosquito_NN1 innate_JJ immunity_NN1 to_II resistance_NN1 ._. Indeed_RR ,_, Dcr2_NP1 initiates_VVZ the_AT exogenous_JJ siRNA_NP1 pathway_NN1 by_II detecting_VVG and_CC cleaving_VVG viral_JJ double-stranded_JJ RNA_NP1 (_( induced_VVN by_II replication_NN1 or_CC potentially_RR secondary_JJ structures_NN2 )_) into_II 21_MC nucleotide_NN1 virus-derived_JJ small_JJ interfering_JJ RNAs_NP2 ,_, a_AT1 critical_JJ step_NN1 in_II this_DD1 antiviral_JJ response_NN1 ._. 
The_AT establishment_NN1 of_IO new_JJ techniques_NN2 for_IF genomics_NN2 and_CC for_IF the_AT analysis_NN1 of_IO differential_JJ gene_NN1 expression_NN1 ,_, such_II21 as_II22 microarrays_NN2 and_CC more_RGR recently_RR high-throughput_JJ sequencing_NN1 ,_, has_VHZ allowed_VVN comparative_JJ studies_NN2 between_II refractory_JJ and_CC susceptible_JJ mosquitoes_NN2 to_TO be_VBI performed_VVN ,_, and_CC are_VBR novel_JJ opportunities_NN2 for_IF in-depth_JJ genetic_JJ studies_NN2 ._. In_II the_AT case_NN1 of_IO DENV2_NP1 /_/ Ae._NP121 aegypti_NP122 interactions_NN2 ,_, comparative_JJ studies_NN2 between_II susceptible_JJ D2S3_NP1 and_CC refractory_JJ Moyo-D_NP1 mosquitoes_NN2 have_VH0 shown_VVN that_CST common_JJ factors_NN2 up-regulated_VVN in_II31 response_II32 to_II33 infection_NN1 include_VV0 endocytosis_NN1 ,_, autophagy_NN1 regulation_NN1 and_CC a_AT1 number_NN1 of_IO other_JJ physiological_JJ processes_NN2 ;_; however_RR ,_, some_DD genes_NN2 linked_VVN to_II immunity_NN1 were_VBDR only_JJ up-regulated_VVN in_II the_AT refractory_JJ strain_NN1 suggesting_VVG a_AT1 further_JJR role_NN1 in_II competence_NN1 [_[ 40_MC ]_] ._. Interestingly_RR ,_, genes_NN2 linked_VVN to_II one_MC1 of_IO the_AT insect_NN1 's_GE immune_NN1 signaling_NN1 pathways_NN2 ,_, the_AT JAK_NP1 /_/ STAT_NP1 pathway_NN1 ,_, previously_RR linked_VVN to_II the_AT control_NN1 of_IO DENV_NP1 in_II this_DD1 mosquito_NN1 [_[ 41_MC ]_] were_VBDR also_RR up-regulated_VVN in_II both_DB2 strains_NN2 in_II31 response_II32 to_II33 infection_NN1 ._. This_DD1 leads_VVZ to_II the_AT question_NN1 of_IO potential_JJ differences_NN2 in_II the_AT JAK_NP1 /_/ STAT_NP1 pathway_NN1 between_II these_DD2 strains_NN2 (_( for_REX21 example_REX22 inexpression_NN1 of_IO antiviral_JJ effectors_NN2 )_) and_CC whether_CSW it_PPH1 is_VBZ really_RR a_AT1 defining_JJ contributor_NN1 to_II competence_NN1 ._. To_TO analyze_VVI this_DD1 question_NN1 ,_, more_RGR detailed_JJ comparative_JJ studies_NN2 on_II this_DD1 pathway_NN1 between_II strains_NN2 would_VM be_VBI required_VVN ._. The_AT same_DA authors_NN2 also_RR compared_VVD sub-strains_NN2 of_IO the_AT Moyo_NP1 Ae._NP121 aegypti_NP122 mosquitoes_NN2 that_DD1 were_VBDR either_RR resistant_JJ (_( MOYO-R_NP1 )_) or_CC susceptible_JJ (_( MOYO-S_NP1 )_) to_II DENV2_NP1 [_[ 42_MC ]_] ._. While_CS again_RT confirming_VVG the_AT important_JJ role_NN1 of_IO the_AT JAK_NP1 /_/ STAT_NP1 pathway_NN1 in_II both_DB2 strains_NN2 ,_, a_AT1 number_NN1 of_IO particularly_RR intriguing_JJ responses_NN2 or_CC genes_NN2 stand_VV0 out_RP ._. 
